Medbox, Inc. Announces the Launch of its New Investor Relations Website

Medbox, Inc. (MDBX) (www.medbox.com), a leading dispensary infrastructure/licensing specialist, patented technology provider, and partner to the cannabis industry, unveiled its new Investor Relations website. The site, www.medbox.com, incorporates numerous features to make browsing for investment information a much faster and informative experience for the Company’s current and potential investors.

The new Investor Relations section features immediate posting of the Company’s press releases as they are issued, as well as the automated posting of SEC filings, XBRL data, Insider Section 16 filings and detailed annual as well as quarterly financial statements. Stock information data such as quotes, charts and historical prices are updated on demand with a 20-minute delay and the Company’s financial tear sheet is updated daily after the market close. There is also an IR calendar featuring upcoming events, conference calls, investor presentations, CEO interviews and media coverage as well as corporate videos and an up-to-date frequently asked question section.

Guy M. Marsala, Medbox’s President, Chief Executive Officer and Chairman of the Board of Directors said, “A significant part of our mission is presenting current and potential investors with the information they want in the quickest and most organized way. We believe our new IR website advances this goal by presenting our investor information in an attractive and easy-to-access format.”

Mr. Marsala continued, “A priority for the IR website is to maximize corporate transparency for the benefit of our investors and we are confident that the new IR website succeeds in providing this transparency. Furthermore, the IR website allows us to archive an extensive range of corporate materials and information that can be easily searched and accessed by any investor at any time.”

Medbox engaged Equisolve, Inc. to design, develop and provide ongoing management for the new IR website. Equisolve is the leading company delivering cutting edge communications solutions for public companies by integrating the company’s corporate website and IR website on a single platform.

Make sure you are first to receive timely information on Medbox when it hits the newswire. Sign up for Medbox’s email news alert system today at: www.medbox.com

About Medbox, Inc.
Medbox (http://www.medbox.com) is the leading dispensary infrastructure and licensing specialist, patented technology provider, and partner to the cannabis industry. Headquartered in Los Angeles, CA, Medbox, through its wholly owned subsidiary, Medicine Dispensing Systems, offers its patented systems, software and consulting services to pharmacies, alternative medicine dispensaries and local governments in the U.S. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical vaporizer product. Medbox, through its newly established subsidiaries, is in development of the following ancillary services tailored to the alternative medicine industry: merchant services and armored transport for cash deposits, cannabidiol research and development, real estate acquisitions and subsequent lease programs to alternative medicine dispensaries, and alternative medicine dispensary management services.

Forward-Looking Statements
Statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not undertake any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

Contact Information
Investor Relations:
Stephen Hart
Hayden IR
+1- 917-658-7878
hart@haydenir.com

Medbox:
For more information on Medbox, please call (800) 762-1452.

Posted in: Press

Comments are closed.